Exploring awareness and knowledge of social egg freezing in Hong Kong
Official title: Current Awareness, Perspective and Knowledge on Social Egg Freezing
Run by Chinese University of Hong Kong · NCT06581666 · Data updated 2026-11-12
This study is trying to find out how much young adults and doctors in Hong Kong know about social egg freezing and if they accept it, to help create better education and support for fertility preservation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | September 1, 2024 |
| Main results expected | August 31, 2029 |
| Study ends | September 1, 2030 |
| Registry record updated | November 12, 2024 |
| Trial ID | NCT06581666 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 18-60 who are interested in or have undergone fertility preservation services.
✕Probably not a fit
Patients with significant psychiatric problems or cognitive delays who cannot provide consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the awareness, knowledge, and acceptance of oocyte cryopreservation among clinicians and young adults in Hong Kong. By utilizing a self-administered questionnaire distributed both in paper form and online, the study seeks to gather insights into the cultural stigma surrounding fertility issues. The findings will inform the development of a culturally appropriate public education program and a referral system to enhance fertility preservation services. Participants will include individuals aged 18-60 who can provide informed consent.
Why it matters
Potential benefit: If successful, this study could lead to improved awareness and utilization of fertility preservation services among young adults in Hong Kong.
How similar studies have gone: While there may be limited studies specifically addressing social egg freezing in Hong Kong, similar approaches in other regions have shown success in raising awareness and improving fertility preservation services.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * People with aged from 18-60 years old Exclusion Criteria: * Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
Where it's running
-
Pui Wah Jacqueline Chung
Hong Kong, Hong Kong Recruiting
Study contacts
- Principal investigator: Pui Wah Jacqueline Chung — Chinese University of Hong Kong
- Study coordinator: Pui Wah Jacqueline Chung
- Email: jacquelinechung@cuhk.edu.hk
- Phone: +852 35051537
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HR20013 for preventing nausea and vomiting in cancer patients receiving chemotherapy
This real-world study tests whether HR20013 helps prevent nausea and vomiting in adults with cancer who are getting chemotherapy.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Ready for Safe Cancer Treatment (RESET): A comprehensive perioperative program for surgical patients
The RESET program tests a structured, multidisciplinary perioperative plan to improve safety and recovery for adults having planned cancer surgery and older adults having planned non cancer-related surgery.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
-
Metastatic liver cancer patient registry from multiple Chinese centers
This is a registry that collects real-world data on adults with liver metastases to understand patterns and prognosis and to support future research.
-
TriAdeno and N-803 vaccine in early prostate cancer on active surveillance
A vaccine combo called TriAdeno plus the N-803 drug is being tested to see if it can help slow or stop growth in men with early-stage, low- to intermediate-risk prostate cancer who are being watched rather than treated right away.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.